Trump Administration Passed on Chance to Secure More of Pfizer Vaccine

by

The pharmaceutical company offered the government a chance to lock in additional supplies before its vaccine was proved effective in clinical trials.

View original article
Contributor: Sharon LaFraniere, Katie Thomas and Noah Weiland